BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27981341)

  • 1. A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.
    Duflot T; Pereira T; Roche C; Iacob M; Cardinael P; Hamza NE; Thuillez C; Compagnon P; Joannidès R; Lamoureux F; Bellien J
    Anal Bioanal Chem; 2017 Mar; 409(7):1845-1855. PubMed ID: 27981341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Determination Method of Epoxyeicosatrienoic Acids and Dihydroxyeicosatrienoic Acids by LC-MS/MS System.
    Mukai Y; Toda T; Takeuchi S; Senda A; Yamashita M; Eliasson E; Rane A; Inotsume N
    Biol Pharm Bull; 2015; 38(10):1673-9. PubMed ID: 26424030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
    Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
    Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
    Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells.
    Jiang H; McGiff JC; Quilley J; Sacerdoti D; Reddy LM; Falck JR; Zhang F; Lerea KM; Wong PY
    J Biol Chem; 2004 Aug; 279(35):36412-8. PubMed ID: 15213230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
    Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide.
    Fang X; Weintraub NL; Oltman CL; Stoll LL; Kaduce TL; Harmon S; Dellsperger KC; Morisseau C; Hammock BD; Spector AA
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2306-14. PubMed ID: 12388281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.
    Fang X; Kaduce TL; Weintraub NL; Harmon S; Teesch LM; Morisseau C; Thompson DA; Hammock BD; Spector AA
    J Biol Chem; 2001 May; 276(18):14867-74. PubMed ID: 11278979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids.
    Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
    Circ Res; 1997 Aug; 81(2):258-67. PubMed ID: 9242187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.
    Powell WS; Rokach J
    Prog Lipid Res; 2013 Oct; 52(4):651-65. PubMed ID: 24056189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide.
    Rand AA; Helmer PO; Inceoglu B; Hammock BD; Morisseau C
    Methods Mol Biol; 2018; 1730():123-133. PubMed ID: 29363071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of 14,15-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid by fluoroimmunoassay.
    Nithipatikom K; Falck JR; Bhatt RK; Hanke CJ; Campbell WB
    Anal Biochem; 1997 Mar; 246(2):253-9. PubMed ID: 9073364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
    Diani-Moore S; Ma Y; Gross SS; Rifkind AB
    Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14,15-epoxyeicosatrienoic acid, 14,15-dihydroxyeicosatrienoic acid, leukotoxin and leukotoxin diol in human plasma as biomarkers of soluble epoxide hydrolase activity in vivo.
    Zhu P; Peck B; Licea-Perez H; Callahan JF; Booth-Genthe C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2487-93. PubMed ID: 21798825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of 3R-hydroxy-polyenoic fatty acids by the yeast Dipodascopsis uninucleata.
    Venter P; Kock JL; Kumar GS; Botha A; Coetzee DJ; Botes PJ; Bhatt RK; Falck JR; Schewe T; Nigam S
    Lipids; 1997 Dec; 32(12):1277-83. PubMed ID: 9438238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle.
    Fang X; Kaduce TL; Weintraub NL; VanRollins M; Spector AA
    Circ Res; 1996 Oct; 79(4):784-93. PubMed ID: 8831502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive and improved throughput UPLC-MS/MS quantitation method of total cytochrome P450 mediated arachidonic acid metabolites that can separate regio-isomers and cis/trans-EETs from human plasma.
    Zeigler M; Whittington D; Sotoodehnia N; Lemaitre RN; Totah RA
    Chem Phys Lipids; 2018 Nov; 216():162-170. PubMed ID: 30201384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
    Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
    Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.
    Yang T; Peng R; Guo Y; Shen L; Zhao S; Xu D
    Lipids Health Dis; 2013 Oct; 12():151. PubMed ID: 24148690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.